NZ's Rua Bioscience scales 2-month high on agreement with Apollo Green
** Rua Bioscience RUA.NZ shares jump as much as 8.3% to
NZ$0.105, biggest intraday pct gain since Nov. 8, 2023
** NZ-based medicinal cannabis co says it has reached an
agreement with Canada's Apollo Green
** Says collaboration with Apollo Green enables cultivation
of co's East Coast Tairawhiti strains in Canada
** Adds Apollo Green to include co's strains in its genetic
library under deal
** Shares hit their highest level since Jan. 22
** RUA down 19.2% YTD, as of last close
(Reporting by Echha Jain in Bengaluru)
((Echha.jain@thomsonreuters.com))
Recent news on Rua Bioscience
See all newsBrief: Rua Bioscience Partners With Curaleaf Laboratories For UK Distribution
Brief: Rua Bioscience Partners To Supply Medicinal MDMA In New Zealand
Brief: Pharmala Biotech Holdings Rua Bioscience And Pharmala Biotech Partner To Supply Medicinal Mdma In New Zealand
Brief: Rua Bioscience Posts Preliminary Unaudited Annual Results
New Zealand's Rua Bioscience FY customer revenue jumps on Australia, NZ growth